2018
DOI: 10.1016/j.pt.2017.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Mining Filarial Genomes for Diagnostic and Therapeutic Targets

Abstract: Filarial infections of humans cause some of the most important neglected tropical diseases. The global efforts for eliminating filarial infections by mass drug administration programs may require additional tools (safe macrofilaricidal drugs, vaccines, and diagnostic biomarkers). The accurate and sensitive detection of viable parasites is essential for diagnosis and for surveillance programs. Current community-wide treatment modalities do not kill the adult filarial worms effectively; hence, there is a need to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 125 publications
0
14
0
Order By: Relevance
“…New data and technologies have promised to speed the discovery and validation of novel therapeutic targets. The release of the B. malayi draft genome initiated a wave of target-based approaches that leverage genomic data, molecular biology, and rational target selection, which allow for the cloning, expression, and screening of putative targets in recombinant systems or exploring the repurposing of approved drugs with known targets [10][11][12][13]. Intrinsic to this process is the assumption that the desired transcript and isoform of a given target is known and amenable to straightforward cloning.…”
Section: Introductionmentioning
confidence: 99%
“…New data and technologies have promised to speed the discovery and validation of novel therapeutic targets. The release of the B. malayi draft genome initiated a wave of target-based approaches that leverage genomic data, molecular biology, and rational target selection, which allow for the cloning, expression, and screening of putative targets in recombinant systems or exploring the repurposing of approved drugs with known targets [10][11][12][13]. Intrinsic to this process is the assumption that the desired transcript and isoform of a given target is known and amenable to straightforward cloning.…”
Section: Introductionmentioning
confidence: 99%
“…For example, several approaches are being employed to identify targets for onchocerciasis serological assays to support programmatic decision-making. 8–11 These efforts should be expanded to include other NTDs. In particular, promising new epitope screening technologies may help to accelerate the identification of novel targets and permutations of targets for serological assays.…”
Section: New Scientific Opportunitiesmentioning
confidence: 99%
“…Though not yet fully implemented in Africa, omics technologies and bioinformatics analyses have aided significantly in the generation of new knowledge toward drug and vaccine target discovery ( Yan et al, 2015 ; Xia, 2017 ). Genomic, transcriptomic and proteomic analyses of pathogens such as filariasis parasites have identified new potential biomarkers that can be invaluable in diagnostics, vaccine and drug development ( Armstrong et al, 2016 ; Bennuru et al, 2017 ). Kumar et al (2007) , using genome wide C. elegans RNA-interference data as proxy, identified a set of 3,059 essential genes in the B. malayi genome, from which 589 were characterized as potential drug targets.…”
Section: Application Of Omics To Vaccine Target Identification and Drmentioning
confidence: 99%